Showing 1151-1160 of 6766 results for "".
Pearls for Injectables: From Toxins to Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pearls-for-injectables-from-toxins-to-fillers/18628/Ava Shamban, MD shares her rationale for thinking of the face in three treatment areas for rejuvenation procedures—upper, middle, and lower. Devising strategies with injections targeted to each area will help patients achieve more natural recountouring while achieving the youthful appearance they dePediatric Atopic Dermatitis And Psoriasis
https://practicaldermatology.com/topics/psoriasis/pediatric-atopic-dermatitis-and-psoriasis/18631/Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many children remain undertreated for their eczema despite the availability of effective treatments and a number of topical and systemic products on the horizon. Dr. Eichenfield also proThe Rising Costs of Prescription Drugs
https://practicaldermatology.com/topics/practice-management/the-rising-costs-or-prescription-drugs/18677/What's really causing the costs of dermatology prescriptions, especially generics, to skyrocket? Jake Levitt, MD and Mark Lebwohl, MD speak to host Neal Bhatia, MD about what's influencing these rising costs, and who, if anyone, is benefiting. Dr. Levitt talks about the rebate system between manufacValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Otezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for pSpend Wisely on Marketing
https://practicaldermatology.com/topics/practice-management/spend-wisely-on-marketing/19061/The best investment in marketing focuses on a long-range plan. If you have good ideas without a firm strategy and follow-through, your investment won't pay off, says Tracy Drumm, Vice President of IF Marketing.Julius Few: "If I could…"
https://practicaldermatology.com/topics/practice-management/julius-few-if-i-could-/19086/If he could buy any one laser or energy based device for his practice, Julius Few, MD says he would invest in another device he already owns! Learn what he had to say and what his experience has been.Harmony XL, Dr. Manjoney
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/harmony-xl-dr-manjoney-/19236/Laser skin treatment, Harmony XL. Dr. Manjoney tells us why her patients love the Harmony XL from Alma Lasers. http://www.AlmaLasers.comHarmony XL, Dr. Rullan
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/harmony-xl-dr-rullan/19237/Laser treatment, Harmony XL. Dr. Rullan shares the many uses of the Harmony XL from Alma Lasers. http://www.AlmaLasers.comCosmeceutical Science
https://practicaldermatology.com/topics/general-topics/cosmeceutical-science/19293/Patti Farris, MD discusses recent developments in cosmeceutical formulation with an emphasis on the latest research on ingredients like botanicals, growth factors, and peptides. She reviews the best evidence for cosmeceuticals and offers tips on product selection and use in a conversation with host